Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Cave

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
British Journal of Cancer|September 7, 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary PathologistsColin R Lindsay, Emily C Shaw, David A Moore, et al.
Journal for Immunotherapy of Cancer|February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinationsAlessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature|April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
British Journal of Cancer|September 7, 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary PathologistsColin R Lindsay, Emily C Shaw, David A Moore, et al.
Journal for Immunotherapy of Cancer|February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinationsAlessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature|April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Pageof 4